Publications

5898 Results

Patient-reported anxiety and fatigue in women enrolled in the RxPONDER trial (SWOG S1007) by menopausal status

Authors
M Loch;J Forschmiedt;I Kang;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;P Rastogi;A Schott;S Shak;P Sharma;D Lew;J Miao;W Barlow;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky;NL Henry
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster abstract P6-05-06
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Patient-reported cognitive impairment in women participating in the RxPONDER trial (SWOG S1007) by menopausal status

Authors
I Kang;J Forschmiedt;M Loch;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;P Rastogi;A Schott;S Shak;P Sharma;D Lew;J Miao;W Barlow;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky;NL Henry
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), oral abstract GS1-04.
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Baseline Insurance and Unplanned Emergency Room Use and Hospitalizations Among Elderly Breast Cancer Patients Participating in SWOG Clinical Trials

Authors
D Hershman;R Vaidya;C Till;W Barlow;M LeBlanc;JM Unger
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), PD6-04, Spotlight Poster Discussion presentation
Year
2022
Research Committee(s)
Multiple sites

Computerized Measurements of Nuclear Morphology Features, Mitosis Rate, and Tubule Formation from H&E Images Predicts Disease-Free Survival in Patients with HR+ & LN+ Invasive Breast Cancer from SWOG S8814

Authors
Y Chen;W Barlow;C Lu;A Janowczyk;G Corredor;S Ganesan;M Feldman;P Fu;H Gilmore;K Albain;L Pusztai;J Rae;D Hayes;A Godwin;A Thompson;A Madabhushi
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX, poster
Year
2022
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

SWOG 1904: Cluster-randomized controlled trial of patient and provider decision support to increase chemoprevention informed choice among women with atypical hyperplasia or lobular carcinoma in situ (MiCHOICE)

Authors
K Crew;G Anderson;K Arnold;A Stieb;J Amenta;C Law;A Sandoval-Leon;S Colonna;T King;D Mangino;S Pruthi;M Grosse-Perdekamp;C Braun-Inglis;S Krisher;L Lee;D Bertoni;S Seaward;T Ballinger;K Wisinski;J Floyd;C Zarwan;L VanderWalde;M Ross;P Steen;S Lo;A Conlin;K Yost;J Ellerton;E Lin;H Pederson;S Sardesai;S Sardesai;C Jernigan;D Hershman;M Neuhouser;B Arun;Rita Kukafka
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster, trials in progress
Year
2022
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S1904

Incidence of Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)

Authors
M Trivedi;J Unger;D Hershman;A Darke;D Hertz;T Brannagan;S Smith;B Schneider;W Irvin;A Hathaway;A Vander Woude;V Gudena;NL Henry;M Fisch
Journal / Conference
Cancer Research Vol 83, Issue 5_Suppl 1 March 2023; San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX, Spotlight Poster Discussion
Year
2022
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1714

Race and Clinical Outcomes in the RxPONDER Trial (SWOG S1007)

Authors
Y Abdou;W Barlow;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;A Schott;S Shak;P Sharma;D Lew;J Miao;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Impact of HER2 low status on clinical outcomes in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): results from SWOG S1007 (RxPONDER)

Authors
L Spring;W Barlow;A Bardia;P Sharma;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX), poster
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Disease

Authors
S Patel;M Othus;YK Chae;M Dennis;S Gordon;B Tan;W Samlowski;E Sharon;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
Society for Immunotherapy of Cancer (SITC) (Nov 8-12,2022, Boston, MA), poster
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Authors
D Luan;Z Chen;L Jakobsen;M Maurer;T El-Galaly;L Nastoupil;J Cerhan;C Flowers;B Link;I Lossos;D Stephens;T Habermann;G Nowakowski;N Bartlett;J Friedberg;B Kahl;J Leonard;K Smedby;M Jerkeman;P Martin
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), oral
Year
2022
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1412, E4494, S1001